{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:13:31Z","timestamp":1781900011857,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["#81572769"],"award-info":[{"award-number":["#81572769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["#31420103915"],"award-info":[{"award-number":["#31420103915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["#2016ZDXM006"],"award-info":[{"award-number":["#2016ZDXM006"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13148-018-0459-2","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T23:32:01Z","timestamp":1519687921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via \u03b2-catenin\/Cdc25c signaling and G2\/M arrest"],"prefix":"10.1186","volume":"10","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxiu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"459_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"459_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/epi.14.79","volume":"7","author":"L Li","year":"2015","unstructured":"Li L, Zhang Y, Fan Y, Sun K, Su X, Du Z, Tsao SW, Loh TK, Sun H, Chan AT, et al. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics. 2015;7:155\u201373.","journal-title":"Epigenomics"},{"key":"459_CR3","doi-asserted-by":"crossref","first-page":"70924","DOI":"10.18632\/oncotarget.12341","volume":"7","author":"T Xiang","year":"2016","unstructured":"Xiang T, Fan Y, Li C, Li L, Ying Y, Mu J, Peng W, Feng Y, Oberst M, Kelly K, et al. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Oncotarget. 2016;7:70924\u201335.","journal-title":"Oncotarget"},{"key":"459_CR4","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1038\/s41598-017-03647-3","volume":"7","author":"J Li","year":"2017","unstructured":"Li J, Zhang M, He T, Li H, Cao T, Zheng L, Guo M. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling. Sci Rep. 2017;7:3325.","journal-title":"Sci Rep"},{"key":"459_CR5","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/onc.2014.201","volume":"34","author":"S Wang","year":"2015","unstructured":"Wang S, Dong Y, Zhang Y, Wang X, Xu L, Yang S, Li X, Dong H, Xu L, Su L, et al. DACT2 is a functional tumor suppressor through inhibiting Wnt\/beta-catenin pathway and associated with poor survival in colon cancer. Oncogene. 2015;34:2575\u201385.","journal-title":"Oncogene"},{"key":"459_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/path.4073","volume":"230","author":"Y Jia","year":"2013","unstructured":"Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer. J Pathol. 2013;230:194\u2013204.","journal-title":"J Pathol"},{"key":"459_CR7","first-page":"710","volume":"4","author":"Y Yu","year":"2014","unstructured":"Yu Y, Yan W, Liu X, Jia Y, Cao B, Yu Y, Lv Y, Brock MV, Herman JG, Licchesi J, et al. DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling. Am J Cancer Res. 2014;4:710\u201324.","journal-title":"Am J Cancer Res"},{"key":"459_CR8","doi-asserted-by":"publisher","first-page":"e2981","DOI":"10.1038\/cddis.2017.385","volume":"8","author":"Y Tan","year":"2017","unstructured":"Tan Y, Li QM, Huang N, Cheng S, Zhao GJ, Chen H, Chen S, Tang ZH, Zhang WQ, Huang Q, Cheng Y. Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway. Cell Death Dis. 2017;8:e2981.","journal-title":"Cell Death Dis"},{"key":"459_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/1940-6207.CAPR-12-0352","volume":"6","author":"J Hou","year":"2013","unstructured":"Hou J, Liao LD, Xie YM, Zeng FM, Ji X, Chen B, Li LY, Zhu MX, Yang CX, Qing Z, et al. DACT2 is a candidate tumor suppressor and prognostic marker in esophageal squamous cell carcinoma. Cancer Prev Res (Phila). 2013;6:791\u2013800.","journal-title":"Cancer Prev Res (Phila)"},{"key":"459_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1096\/fj.06-6246com","volume":"21","author":"Y Su","year":"2007","unstructured":"Su Y, Zhang L, Gao X, Meng F, Wen J, Zhou H, Meng A, Chen YG. The evolutionally conserved activity of Dapper2 in antagonizing TGF-beta signaling. FASEB J. 2007;21:682\u201390.","journal-title":"FASEB J"},{"key":"459_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.1100569","volume":"306","author":"L Zhang","year":"2004","unstructured":"Zhang L, Zhou H, Su Y, Sun Z, Zhang H, Zhang L, Zhang Y, Ning Y, Chen YG, Meng A. Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. Science. 2004;306:114\u20137.","journal-title":"Science"},{"key":"459_CR12","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.3892\/mmr.2015.3276","volume":"11","author":"B Sun","year":"2015","unstructured":"Sun B, Xu M. Matrine inhibits the migratory and invasive properties of nasopharyngeal carcinoma cells. Mol Med Rep. 2015;11:4158\u201364.","journal-title":"Mol Med Rep"},{"key":"459_CR13","first-page":"37","volume":"1755","author":"M Bjorklund","year":"2005","unstructured":"Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005;1755:37\u201369.","journal-title":"Biochim Biophys Acta"},{"key":"459_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1128\/MCB.01180-14","volume":"35","author":"A Suzuki","year":"2015","unstructured":"Suzuki A, Pelikan RC, Iwata J. WNT\/\u03b2-catenin signaling regulates multiple steps of myogenesis by regulating step-specific targets. Mol Cell Biol. 2015;35:1763\u201376.","journal-title":"Mol Cell Biol"},{"key":"459_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/2211-5463.12206","volume":"7","author":"MC de Gooijer","year":"2017","unstructured":"de Gooijer MC, van den Top A, Bockaj I, Beijnen JH, Wurdinger T, van Tellingen O. The G2 checkpoint-a node-based molecular switch. FEBS Open Bio. 2017;7:439\u201355.","journal-title":"FEBS Open Bio"},{"key":"459_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF00685909","volume":"33","author":"J Liebmann","year":"1994","unstructured":"Liebmann J, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines. Cancer Chemother Pharmacol. 1994;33:331\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"459_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1349-7006.1999.tb00800.x","volume":"90","author":"H Takeda","year":"1999","unstructured":"Takeda H, Haisa M, Naomoto Y, Kawashima R, Satomoto K, Yamatuji T, Tanaka N. Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line. Jpn J Cancer Res. 1999;90:677\u201384.","journal-title":"Jpn J Cancer Res"},{"key":"459_CR18","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265\u201379.","journal-title":"Oncogene"},{"key":"459_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5732\/cjc.011.10080","volume":"30","author":"LL Li","year":"2011","unstructured":"Li LL, Shu XS, Wang ZH, Cao Y, Tao Q. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chin J Cancer. 2011;30:231\u20139.","journal-title":"Chin J Cancer"},{"key":"459_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683\u201392.","journal-title":"Cell"},{"key":"459_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000312","volume":"9","author":"Q Tao","year":"2007","unstructured":"Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007;9:1\u201324.","journal-title":"Expert Rev Mol Med"},{"key":"459_CR22","doi-asserted-by":"publisher","first-page":"e112336","DOI":"10.1371\/journal.pone.0112336","volume":"9","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Herman JG, Brock MV, Sheng J, Zhang M, Liu B, Guo M. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling. PLoS One. 2014;9:e112336.","journal-title":"PLoS One"},{"key":"459_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4161\/epi.24113","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Yang Y, Liu X, Herman JG, Brock MV, Licchesi JD, Yue W, Pei X, Guo M. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma. Epigenetics. 2013;8:373\u201382.","journal-title":"Epigenetics"},{"key":"459_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1477-7819-11-57","volume":"11","author":"S Gao","year":"2013","unstructured":"Gao S, Yang Z, Zheng ZY, Yao J, Zhang F, Wu LM, Xie HY, Zhou L, Zheng SS. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing. World J Surg Oncol. 2013;11:57.","journal-title":"World J Surg Oncol"},{"key":"459_CR25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483\u20137.","journal-title":"Science"},{"key":"459_CR26","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1101\/gad.11.24.3286","volume":"11","author":"KM Cadigan","year":"1997","unstructured":"Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286\u2013305.","journal-title":"Genes Dev"},{"key":"459_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1534-5807(02)00140-5","volume":"2","author":"BN Cheyette","year":"2002","unstructured":"Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC, Khlebtsova N, Fox EP, Earnest T, Moon RT. Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell. 2002;2:449\u201361.","journal-title":"Dev Cell"},{"key":"459_CR28","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1242\/dev.01520","volume":"131","author":"JS Waxman","year":"2004","unstructured":"Waxman JS, Hocking AM, Stoick CL, Moon RT. Zebrafish Dapper1 and Dapper2 play distinct roles in Wnt-mediated developmental processes. Development. 2004;131:5909\u201321.","journal-title":"Development"},{"key":"459_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2010.02.023","volume":"37","author":"RW Deibler","year":"2010","unstructured":"Deibler RW, Kirschner MW. Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts. Mol Cell. 2010;37:753\u201367.","journal-title":"Mol Cell"},{"key":"459_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4161\/cc.3.6.906","volume":"3","author":"E Perdiguero","year":"2004","unstructured":"Perdiguero E, Nebreda AR. Regulation of Cdc25C activity during the meiotic G2\/M transition. Cell Cycle. 2004;3:733\u20137.","journal-title":"Cell Cycle"},{"key":"459_CR31","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1158\/1078-0432.CCR-09-3178","volume":"16","author":"L Li","year":"2010","unstructured":"Li L, Tao Q, Jin H, van Hasselt A, Poon FF, Wang X, Zeng MS, Jia WH, Zeng YX, Chan AT, Cao Y. The tumor suppressor UCHL1 forms a complex with p53\/MDM2\/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res. 2010;16:2949\u201358.","journal-title":"Clin Cancer Res"},{"key":"459_CR32","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/jcb.25135","volume":"116","author":"T Chen","year":"2015","unstructured":"Chen T, Long B, Ren G, Xiang T, Li L, Wang Z, He Y, Zeng Q, Hong S, Hu G. Protocadherin20 acts as a tumor suppressor gene: epigenetic inactivation in nasopharyngeal carcinoma. J Cell Biochem. 2015;116:1766\u201375.","journal-title":"J Cell Biochem"},{"key":"459_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CEJ.0b013e328350b097","volume":"21","author":"D He","year":"2012","unstructured":"He D, Zeng Q, Ren G, Xiang T, Qian Y, Hu Q, Zhu J, Hong S, Hu G. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. Eur J Cancer Prev. 2012;21:569\u201375.","journal-title":"Eur J Cancer Prev"},{"key":"459_CR34","first-page":"789","volume":"4","author":"FL Sung","year":"2014","unstructured":"Sung FL, Cui Y, Hui EP, Li L, Loh TK, Tao Q, Chan AT. Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma. Am J Cancer Res. 2014;4:789\u2013800.","journal-title":"Am J Cancer Res"},{"key":"459_CR35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/sj.onc.1209154","volume":"25","author":"J Ying","year":"2006","unstructured":"Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 2006;25:1070\u201380.","journal-title":"Oncogene"},{"key":"459_CR36","doi-asserted-by":"publisher","first-page":"e29783","DOI":"10.1371\/journal.pone.0029783","volume":"7","author":"T Xiang","year":"2012","unstructured":"Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K, et al. The ubiquitin peptidase UCHL1 induces G0\/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS One. 2012;7:e29783.","journal-title":"PLoS One"},{"key":"459_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0002-9440(10)65157-7","volume":"155","author":"Q Tao","year":"1999","unstructured":"Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease: application of PCR-based analysis. Am J Pathol. 1999;155:619\u201325.","journal-title":"Am J Pathol"},{"key":"459_CR38","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/hmg\/11.18.2091","volume":"11","author":"Q Tao","year":"2002","unstructured":"Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, Robertson KD. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet. 2002;11:2091\u2013102.","journal-title":"Hum Mol Genet"},{"key":"459_CR39","doi-asserted-by":"publisher","first-page":"e47942","DOI":"10.1371\/journal.pone.0047942","volume":"7","author":"MI Husseiny","year":"2012","unstructured":"Husseiny MI, Kuroda A, Kaye AN, Nair I, Kandeel F, Ferreri K. Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS One. 2012;7:e47942.","journal-title":"PLoS One"},{"key":"459_CR40","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/bcr3399","volume":"15","author":"X Yin","year":"2013","unstructured":"Yin X, Xiang T, Li L, Su X, Shu X, Luo X, Huang J, Yuan Y, Peng W, Oberst M, et al. DACT1, an antagonist to Wnt\/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Res. 2013;15:R23.","journal-title":"Breast Cancer Res"},{"key":"459_CR41","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00018-013-1485-z","volume":"71","author":"L Li","year":"2014","unstructured":"Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting beta-catenin and AKT signaling but frequently methylated in common carcinomas. Cell Mol Life Sci. 2014;71:2179\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"459_CR42","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/onc.2009.92","volume":"28","author":"XT Hu","year":"2009","unstructured":"Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, et al. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene. 2009;28:2466\u201375.","journal-title":"Oncogene"},{"key":"459_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yexcr.2015.01.017","volume":"332","author":"H Mu","year":"2015","unstructured":"Mu H, Wang N, Zhao L, Li S, Li Q, Chen L, Luo X, Qiu Z, Li L, Ren G, et al. Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer. Exp Cell Res. 2015;332:179\u201389.","journal-title":"Exp Cell Res"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0459-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T18:56:21Z","timestamp":1603911381000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-018-0459-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1186\/s13148-018-0459-2","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the Institutional Ethics Committees of the First Affiliated Hospital of Chongqing Medical University (#20130306) and conformed to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}